I agree that this site is using cookies. You can find further informations here.
X
Menon, Sujatha
82  results:
Search for persons X
?
1

Risk of Venous Thromboembolism With Tofacitinib Versus Tumo..:

Charles‐Schoeman, Christina ; Fleischmann, Roy ; Mysler, Eduardo...
Arthritis & Rheumatology.  76 (2024)  8 - p. 1218-1229 , 2024
Link: https://doi.org/10.1002/..
 
?
2

Advancing the utilization of real‐world data and real‐world..:

Liu, Jing ; Rowland‐Yeo, Karen ; Winterstein, Almut...
Clinical and Translational Science.  17 (2024)  4 - p. , 2024
Link: https://doi.org/10.1111/..
 
?
3

Artificial Intelligence for Quantitative Modeling in Drug D..:

Terranova, Nadia ; Renard, Didier ; Shahin, Mohamed H....
Clinical Pharmacology & Therapeutics.  115 (2023)  4 - p. 658-672 , 2023
Link: https://doi.org/10.1002/..
 
?
4

Impact of cardiovascular risk enrichment on incidence of ma..:

Dougados, Maxime ; Charles-Schoeman, Christina ; Szekanecz, Zoltán...
Annals of the Rheumatic Diseases.  82 (2023)  4 - p. 575-577 , 2023
Link: https://doi.org/10.1136/..
 
?
5

Clinical Pharmacology Applications of Real‐World Data and R..:

Zhu, Rui ; Vora, Bianca ; Menon, Sujatha...
Clinical Pharmacology & Therapeutics.  114 (2023)  4 - p. 751-767 , 2023
Link: https://doi.org/10.1002/..
 
?
6

Rheumatoid arthritis disease activity and adverse events in..:

Karpouzas, George A. ; Szekanecz, Zoltán ; Baecklund, Eva...
Therapeutic Advances in Musculoskeletal Disease.  15 (2023)  - p. , 2023
Link: https://doi.org/10.1177/..
 
?
7

Malignancy risk with tofacitinib versus TNF inhibitors in r..:

Curtis, Jeffrey R ; Yamaoka, Kunihiro ; Chen, Yi-Hsing...
Annals of the Rheumatic Diseases.  82 (2022)  3 - p. 331-343 , 2022
Link: https://doi.org/10.1136/..
 
?
8

Risk of major adverse cardiovascular events with tofacitini..:

Charles-Schoeman, Christina ; Buch, Maya H ; Dougados, Maxime...
Annals of the Rheumatic Diseases.  82 (2022)  1 - p. 119-129 , 2022
Link: https://doi.org/10.1136/..
 
?
9

Use of Tofacitinib in the Context of COVID‐19 Vaccination: ..:

Mortezavi, Mahta ; Menon, Sujatha ; Lee, Kristen.
Arthritis & Rheumatology.  73 (2021)  9 - p. 1768-1769 , 2021
Link: https://doi.org/10.1002/..
 
?
10

Efficacy and safety of tofacitinib modified-release 11 mg o..:

Cohen, Stanley B ; Pope, Janet ; Haraoui, Boulos...
RMD Open.  7 (2021)  2 - p. e001673 , 2021
Link: https://doi.org/10.1136/..
 
?
11

Tofacitinib for the treatment of ankylosing spondylitis: a ..:

Deodhar, Atul ; Sliwinska-Stanczyk, Paula ; Xu, Huji...
Annals of the Rheumatic Diseases.  80 (2021)  8 - p. 1004-1013 , 2021
Link: https://doi.org/10.1136/..
 
?
12

An Integrated Analysis of the Safety of Tofacitinib in Psor..:

Burmester, Gerd R. ; Curtis, Jeffrey R. ; Yun, Huifeng...
Drug Safety.  43 (2020)  4 - p. 379-392 , 2020
Link: https://doi.org/10.1007/..
 
?
13

Safety and Efficacy of Tofacitinib in Patients with Active ..:

Nash, Peter ; Coates, Laura C. ; Kivitz, Alan J....
Rheumatology and Therapy.  7 (2020)  3 - p. 553-580 , 2020
Link: https://doi.org/10.1007/..
 
?
14

Application of Physiologically Based Pharmacokinetic Modeli..:

Tse, Susanna ; Dowty, Martin E. ; Menon, Sujatha..
The Journal of Clinical Pharmacology.  60 (2020)  12 - p. 1617-1628 , 2020
Link: https://doi.org/10.1002/..
 
?
15

Population pharmacokinetics of tofacitinib in patients with..:

Xie, Rujia ; Deng, Chenhui ; Wang, Qiang...
Int. Journal of Clinical Pharmacology and Therapeutics.  57 (2019)  9 - p. 464-473 , 2019
Link: https://doi.org/10.5414/..
 
1-15